Results 121 to 130 of about 15,364 (179)

Real-World Use of Avatrombopag in Children and Adolescents With Immune Thrombocytopenia. [PDF]

Pediatr Blood Cancer
Harris EM, Montcrieff C, O'Farrell C, Konde P, Lambert MP, Grimes AB, Grace RF.   +6 more
europepmc   +1 more source

Thrombopoietin-Rezeptoragonisten

Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, 2011
openaire   +1 more source

Impact of Primary Chronic Immune Thrombocytopenia and Thrombopoietin Receptor Agonists Treatment Instructions on Daily Living: Results of a Multinational Cross-Sectional Survey. [PDF]

Patient Prefer Adherence
Zwaginga JJ, Nagalla S, Linden M, Lindberg MH, Kruse C, Morgan M, Yssing C, Decise D, Putnik M, Rich C.   +9 more
europepmc   +1 more source

Recombinant human thrombopoietin as a novel platelet-driven regulator accelerating hepatic regeneration in acute liver failure. [PDF]

Front Pharmacol
Shen Y, Han F, Wang T, Jing L, Luo Y, Ha F, Lu Y, Liang J.   +7 more
europepmc   +1 more source

Combined mesenchymal stem cells and telitacicept therapy for Evans syndrome refractory to various immunosuppressive: a case report. [PDF]

Res Pract Thromb Haemost
Liu W, Dong H, Xue F, Pei X, Han Z, Yang R, Zhang L.   +6 more
europepmc   +1 more source

Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model. [PDF]

Blood Cancer J
Tavernari L, Bertesi M, Neroni A, Papa E, Rontauroli S, Bianchi E, Mirabile M, Norfo R, Parenti S, Tombari C, Carretta C, Malerba M, Fabbiani L, Guglielmelli P, Losi L, Tagliafico E, Vannucchi AM, Manfredini R, MYNERVA (MYeloid NEoplasms Research Venture AIRC) investigators.   +18 more
europepmc   +1 more source

Successful Management of Relapsed Severe Immune Thrombocytopenia Using Avatrombopag: A Case Report. [PDF]

Case Rep Hematol
Almutairi S, Warsi A, Hejazi A, Melibari E, Jar R, Almutairi A, Abughasham A, Firaque N.   +7 more
europepmc   +1 more source

Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial.

BMJ
Chen Y, Xu Y, Dai J, Sun T, Li H, Hua Z, Zhou Z, Zhou H, Yan Z, Zhao X, Xue F, Liu W, Liu X, Fu R, Wang W, Chi Y, Dong H, Ju M, Dai X, Gu W, Pei X, Yang R, Zhang L.   +22 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Thrombopoietin — Clinically Realized?

New England Journal of Medicine, 1997
For approximately 30 years, hematologists have sought the humoral regulator of platelet production, thrombopoietin.1 Although a factor with the appropriate physiologic effects was partially purifie...
exaly   +3 more sources